Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mengni Ran"'
Publikováno v:
International Journal of Nanomedicine. 15:9703-9715
Introductions Ovarian cancer is a stubborn malignancy of gynecological system with a high mortality rate. Docetaxel (DTX), the second-generation of anti-tumor drug Taxane, has shown superior efficacy over classic paclitaxel (PTX) in certain cancers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21b2c127dfb777416e311a99e2326f7f
https://doi.org/10.2147/ijn.s274083
https://doi.org/10.2147/ijn.s274083
Autor:
Lianbin Wen, Xin Zan, Qidi Pang, Yuzhu Hu, Songping Zheng, Mengni Ran, Xiang Gao, Xiang Wang, Bilan Wang
Publikováno v:
Chinese Chemical Letters. :108224
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4a21ec2d8c9a4c0d1047515f877a8ad
https://doi.org/10.1016/j.cclet.2023.108224
https://doi.org/10.1016/j.cclet.2023.108224
Autor:
Jing Chen, Wen Nie, Zhiyong Qian, Xiaoxiao Liu, Junming Miao, Tingting Yang, Bilan Wang, Xiang Gao, Ting Yu, Yunzhu Lin, Xiao Liang, Xue Mi, Mengni Ran, Zehuo Hong
Publikováno v:
Small methods. 5(5)
Acquired chemoresistance presents a major clinical impediment, which is an urgent problem to be solved. Interestingly, myeloma cell leukemia-1 (MCL-1) and folate receptor expression levels are higher in chemotherapy-resistant patients than in pretrea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7358fe815964441ec3d4ebb2fc849ac
https://pubmed.ncbi.nlm.nih.gov/34928100
https://pubmed.ncbi.nlm.nih.gov/34928100
Autor:
Yunfeng Lin, Xiang Gao, Yin Wu, Tingting Yang, Xiaoxiao Liu, Zhiyong Qian, Tingting Li, Mengni Ran, Yuzhu Hu
Publikováno v:
Materials Today Nano. 17:100151
The functions of immune cells are regulated by stimulatory and inhibitory signals. Immune stimulating factors provoke the activation of immune cells and the release of cytotoxic cytokines such as IFN-γ, which can induce overexpression of PD-L1 on tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b39ff1cf66c1532f995464316e46ab4
https://doi.org/10.1016/j.mtnano.2021.100151
https://doi.org/10.1016/j.mtnano.2021.100151
Autor:
Yihong He, Tingting Yang, Wen Nie, Yan Ju, Ting Yu, Mengni Ran, Zehua Hong, Xin Zan, Xiang Gao
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 11, Iss 10, Pp 1-13 (2020)
Cell Death and Disease, Vol 11, Iss 10, Pp 1-13 (2020)
Two of the biggest hurdles in the deployment of chemotherapeutics against glioma is a poor drug concentration at the tumor site and serious side effects to normal tissues. Nanocarriers delivering different drugs are considered to be one of the most p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::621123b601412bda86790752459c276d
http://europepmc.org/articles/PMC7595144
http://europepmc.org/articles/PMC7595144
Publikováno v:
International Journal of Nanomedicine
Introductions Ovarian cancer is a stubborn malignancy of gynecological system with a high mortality rate. Docetaxel (DTX), the second-generation of anti-tumor drug Taxane, has shown superior efficacy over classic paclitaxel (PTX) in certain cancers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb21f119c1507d38e7913db5ab4454f7
https://pubmed.ncbi.nlm.nih.gov/33299312
https://pubmed.ncbi.nlm.nih.gov/33299312